Early study found it had high accuracy, but experts say it won't replace colonoscopy anytime soon
by andy73 on Tue May 04, 2010 02:57 AM
Very interesting article about Amygdalin and studies done with it at Sloan Kettering
The Ralph Moss Story (in his own words)excerpted from www.cancerdecisions.com
“In 1974, I began working at Memorial Sloan-Kettering Cancer Center, the world’s leading cancer treatment hospital. I was an idealistic and eager young science writer, sincerely proud to be part of Sloan Kettering and Nixon’s “War On Cancer.” Ever since I was a kid, my main heroes were scientists (with the Brooklyn Dodgers running aclose second!) The job at Sloan-Kettering seemed like a dream come true for me. I wanted to be part of the winning team that finally beat cancer.
Within three years, I had risen to the position of Assistant Director of Public Affairs at the Hospital. At the time, I was 34 years old, married to my high-school sweetheart, and we had a daughter and son, then 9 and 7 years old. We had dreams of buying a house and saving for the kids’ education, so you can imagine how thrilled we were when I was promoted, with a huge raise, glowing feedback from my bosses, and was told that perks of the job would eventually include reduced tuition for the kids at New York University. Needless to say, we all were really counting on my “bright future” at Memorial Sloan-Kettering. But something soon happened that changed the course of my life forever.
A big part of my job as Assistant Director of Public Affairs was to write press releases for the media about cancer news and to write the inhospital newsletter. I also handled calls from the press and public about cancer issues. So I was just doing a normal day’s work (or so I thought) when I began interviewing an esteemed scientist at the Hospital for a newsletter article I was working on. It turned out that the scientist, Dr. Kanematsu Sugiura, had repeatedly gotten positive results shrinking tumors in mice studies with a natural substance called amygdalin (You may have heard of it as “laetrile”.) Excitedly (and naively!) I told my “discovery” of Sugiura’s work to the Public Affairs Director and other superiors, and laid out my plans for an article about it.
Then I got the shock of my life.They insisted that I stop working on this story immediately and never pick it up again. Why? They said that Dr. Sugiura’s work was invalid and totally meaningless. But I had seen the results with my own eyes! And I knew Dr. Sugiura was a true scientist and an ethical person. Then my bosses gave me the order that I’ll never forget: They told me to lie. Instead of the story I had been planning to write, they ordered me to write an article and press releases for all the major news stationsemphatically stating that all amygdalin studies were negative and that the substance was worthless for cancer treatment. I protested and tried to reason with them, but it fell on deaf ears.
I will never forget how I felt on the subway ride home that day. My head was spinning with a mixture of strong feelings- confusion, shock, disappointment, fear for my own livelihood and my family’s future, and behind it all, an intense need to know why this cover-up was happening. After long talks with my wife and parents (who were stunned, as you can imagine) I decided to put off writing any amygdalin press releases as long as I could while I discreetly lookedinto the whole thing some more on my own time. Everyone at the office seemed happy just to drop the whole thing, and we got busy with other less controversial projects.
So in the next few months, I was able to do my own investigating to answer the big question I couldn’t let go of: Who were these people I worked for and why would they want to suppress positive results in cancer research? My files grew thick as I uncovered more and morefascinating - and disturbing - facts. I had never given any thought to the politics of cancer before. Now I was putting together the pieces as I learned that:
The people on Sloan-Kettering’s Board of Directors were a“Who’s Who” of investors in petrochemical and otherpolluting industries. In other words, the hospital was beingrun by people who made their wealth by investing in the worst cancer-causing things on the planet. CEOs of top pharmaceutical companies that produced cancer drugs also dominated the Board. They had an obvious vested interest in promoting chemotherapy and undermining natural therapies.The Chairman and the President of Bristol-Myers Squibb, the world’s leading producer of chemotherapy, held highpositions on MSKCC’s Board. Of the nine members of the Hospital’s powerful InstitutionalPolicy Committee, seven had ties to the pharmaceuticalindustry The Hospital itself invested in the stock of these same drugcompanies. Directors of the biggest tobacco companies in the U.S., Phillip Morris and RJR Nabisco held places of honor on the Board. Six Board Directors also served on the Boards of The New York Times, CBS, Warner Communications, Readers Digest, and other media giants.Not surprisingly, profits from chemotherapy drugs were skyrocketing and the media glowingly promoted every new drug as a “breakthrough” in cancer. I kept all my notes in my filing cabinet at work. I had no idea what I would ever do with them. I just knew that I had to get to the bottom of it, for myself.
Meanwhile, the public’s interest in laetrile refused to go away. A lot of people were going across the border to Mexican clinics to get the stuff and my secretary’s phone was ringing off the hook with people wanting to know what Sloan-Kettering thought of its value. I was onceagain told to give out the news that the studies had all been negative. At home, I called my family together for a meeting. with their support, I decided I couldn’t lie on behalf of the Hospital. In November of 1977, I stood up at a press conference and blew the whistle on Memorial Sloan Kettering Cancer Center’s suppression of positive results with amygdalin. It felt like jumping off the highest divingboard, but I had no doubt I was doing the right thing. I was fired the next day for “failing to carry out his most basic responsibilities” as the Hospital described it to the New York Times. In other words, failing to lie to the American people.When I tried to pick up my things in my office, I found my files had been padlocked and two armed Hospital guards escorted me from the premises.
Luckily for all of us, I have a very smart wife who all along had been making copies of my research notes and had put a complete extra set of files in a safe place. Those notes turned into my first book, The Cancer Industry, which is still in print (in an updated version) and available in bookstores.That dramatic day, when I stood up in front of the packed press conference and told the truth, was the beginning of a journey I never could have predicted. I was launched on a mission that I’m still on today – helping cancer patients find the truth about the best cancer treatments.
by andy73 on Wed May 05, 2010 10:59 PM
previous link not working for some reason
by andy73 on Sat Mar 03, 2012 03:24 AM
Article on 13 yr Lymphoma survivor, his diet, and apricot kernels
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
Did you or your loved one seek a second opinion before starting cancer treatment?
No, but we got a second opinion after we started treatment
We care about your feedback. Let us know how we can improve your CancerCompass experience.